Two clinical studies open up new perspectives for the functional use of Montmorency tart cherries in inflammation prevention and metabolic health management.
Until recently, tart cherries – particularly the Montmorency variety – were mainly known in the sports world for their benefits on muscle recovery.
Today, however, new clinical studies reveal their potential in counteracting systemic inflammation and supporting metabolism.
In two recent studies conducted on healthy subjects, researchers investigated the effect of supplementation with concentrated tart cherry extracts on certain biomarkers related to oxidative stress and inflammation.
The first study – a randomized, double-blind, placebo-controlled clinical trial – involved 25 adults with slightly elevated fasting uric acid levels.
Participants consumed a dose of concentrated Montmorency tart cherry powder (CherryPURE®) together with a purine-rich meal, in order to assess potential effects on blood glucose and inflammation.
The results showed no significant effect on postprandial uric acid levels, but a 4.2% reduction in post-meal blood glucose compared to placebo was observed, along with slight changes in the levels of certain inflammatory cytokines.
The second study, also randomized and placebo-controlled, used a standardized European tart cherry extract (NordicCherry®).
Ten healthy subjects took 500 mg per day of the extract for four weeks.
At the end of the intervention, a significant reduction of 37.4% in urate levels and a 23% decrease in C-reactive protein (CRP), a biomarker of systemic inflammation, were observed.
According to the researchers, regular intake of the extract showed a tangible impact on reducing inflammation and regulating uric acid metabolism, suggesting a potential role for tart cherries in the prevention of chronic inflammation and the promotion of metabolic health.
While the first study suggests modest and limited effects, the second provides stronger evidence in support of tart cherries as a functional ingredient capable of contributing to systemic well-being, even in healthy individuals.
Thanks to their polyphenol content, tart cherries are confirmed not only as beneficial for physical recovery, but also as a promising daily support in the prevention of mild inflammatory and metabolic conditions.
A natural ally for those who view nutrition as a key to long-term health.
Source: www.supplysidesj.com
Image source: Onlymyhealth.com
14 May 2025
The Meda™ cherry breeding program celebrates 15 years of innovation, showing outstanding results in Europe and Chile. With Kordia-level quality and earlier harvest, these premium varieties target top-tier markets, including China, with growing export potential.
06 Jun 2023
Cherry growers are looking for solutions to improve the efficiency of their plants, guarantee the product quality demanded by the markets and reduce production costs. These include the mechanisation of certain cultivation operations such as pruning and harvesting.
03 Jul 2026
Research in Moldova on sweet cherry shows Thin spindle improves yield, fruit quality and canopy management in high-density orchards on Gisela 6, while Improved thin spindle boosts large premium fruit, uniformity and commercial value for modern intensive cherry production.
03 Jul 2026
Chilean cherries 2025/26 face a more saturated China market, flat FOB prices and rising pressure on quality, timing and destinations. Diversification toward the United States and other markets is becoming crucial to protect Chile’s profitability and fruit exports now.
